Download PDF
Thromb Haemost 1983; 49(03): 217-223
DOI: 10.1055/s-0038-1657366
Original Article
Schattauer GmbH Stuttgart

Influence of Plasma Fibronectin on the Response to Infusion of Thrombin and Adenosine Diphosphate

J E Kaplan
The Department of Physiology, Neil Heilman Medical Research Building, Albany Medical College of Union University, Albany, N.Y., U.S.A.
,
P W Snedeker
The Department of Physiology, Neil Heilman Medical Research Building, Albany Medical College of Union University, Albany, N.Y., U.S.A.
,
S H Baum
The Department of Physiology, Neil Heilman Medical Research Building, Albany Medical College of Union University, Albany, N.Y., U.S.A.
,
D G Moon
The Department of Physiology, Neil Heilman Medical Research Building, Albany Medical College of Union University, Albany, N.Y., U.S.A.
,
F L Minnear
The Department of Physiology, Neil Heilman Medical Research Building, Albany Medical College of Union University, Albany, N.Y., U.S.A.
› Author Affiliations
Further Information

Publication History

Received 05 August 1982

Accepted 06 April 1983

Publication Date:
18 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

An important physiological anti-thrombotic function has been suggested for plasma fibronectin and the reticuloendothelial system. The current study evaluated the effects of specific immunological fibronectin depletion and fibronectin supplementation upon resistance to infusion of thrombin and ADP in terms of mortality, mean arterial blood pressure and circulating levels of platelets, fibrinogen and fibrin degradation products. Mortality data indicated that rats with reduced fibronectin levels had reduced resistance to thrombin or adenosine diphosphate infusion. The increased lethality was characterized by reduced circulating levels of fibrinogen and platelets while fibrin degradation product levels rose. The infusion of ADP or thrombin in fibronectin supplemented rats failed to elicit higher mortality or reduce fibrinogen or platelet levels further. These data are consistent with the hypothesis that resistance to excessive coagulation and/or platelet aggregation is correlated to circulating plasma fibronectin levels. It is suggested that by direct effects and/ or acting as an opsonin for RES phagocytosis, plasma fibronectin acts as an important anti-thrombotic mechanism.

Keywords

Plasma fibronectin - Thrombosis - Reticuloendothelial system Adenosine diphosphate - Thrombin - Platelets - Fibrinogen
 

  • References

  • 1 Saba TM, Jaffe E. Plasma fibronectin (opsonic glycoprotein): Its synthesis by vascular endothelial cells and role in cardiopulmonary integrity as related to reticuloendothelial function. Am J Med 1980; 68: 577-594
    CrossrefPubMedGoogle Scholar
  • 2 Kaplan JE. Physiological and pathological factors determining phagocytosis. RES and the Pathogenesis of Liver Disease. Lier H, Green M. (eds). Elsevier, North Holland Biomedical Press; Amsterdam: 1980. pp 55-68
    Google Scholar
  • 3 Kaplan JE. The role of the reticuloendothelial system in the control of hemostatic and thrombotic mechanisms. Chapter 7 in: Physiology of the Reticuloendothelial System. Saba TM, Altura B. (eds). Raven Press; New York: 1980. pp. 111-129
    Google Scholar
  • 4 Mosesson MW, Amrani DL. The structure and biologic activities of plasma fibronectin. Blood 1980; 56: 145-158
    PubMedGoogle Scholar
  • 5 Sherman LA, Harwig S, Lee J. In vitro and in vivo clearance of fibrinogen-fibrin complexes. J Lab Clin Med 1975; 86: 100-111
    PubMedGoogle Scholar
  • 6 Kaplan JE, Saba TM. Platelet removal from the circulating by the liver and spleen. Am J Physiol 1978; 235: H314-H320
    PubMedGoogle Scholar
  • 7 Spaet TH, Horowitz HT, Zucker-Franklin D, Clintron J, Bienzenski JJ. Reticuloendothelial clearance of blood thromboplastin by rats. Blood 1961; 17: 196-205
    PubMedGoogle Scholar
  • 8 Gans H, Lowman JT. Uptake of fibrin and fibrin degradation products by the isolated perfused rat liver. Blood 1967; 29: 525-539
    PubMedGoogle Scholar
  • 9 Lee L, McCluskey RJ. Immunohistochemical demonstration of the reticuloendothelial clearance of circulating fibrin aggregates. J Exp Med 1962; 116: 611-617
    CrossrefPubMedGoogle Scholar
  • 10 Jilek F, Hermann H. Cold-insoluble globulin (fibronectin). IV. Affinity to soluble collagen of various types. Hoppe-Seyler’s Z Physiol Chem 1978; 359: 247-250
    PubMedGoogle Scholar
  • 11 Zucker MB, Mosesson MW, Broekman MJ, Kaplan JL. Release of platelet fibronectin (cold-insoluble globulin) from alpha granules induced by thrombin or collagen; lack of requirement for plasma fibronectin in ADP-induced aggregation. Blood 1979; 54: 08-12
    PubMedGoogle Scholar
  • 12 Engvall E, Ruoslahti E. Binding of a soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer 1977; 20: 01-12
    CrossrefPubMedGoogle Scholar
  • 13 Blumenstock FA, Saba TM, Weber P. An affinity method for the rapid purification of opsonic aIpha-2-SB glycoprotein from serum. Adv Shock Res 1979; 02: 55-71
    PubMedGoogle Scholar
  • 14 Saba TM. Prevention of liver reticuloendothelial system host defense failure after surgery by intravenous opsonic glycoprotein therapy. Ann Surg 1978; 188: 142-152
    CrossrefPubMedGoogle Scholar
  • 15 Kaplan JE, Saba TM, Cho E. Serological modifications of reticuloendothelial capacity and altered resistance to traumatic shock. Circ Shock 1976; 03: 203-210
    PubMedGoogle Scholar
  • 16 Blumenstock FA, Weber P, Saba TM, Laffin R. Electroimmunoassay of alpha-2-opsonic protein during reticuloendothelial blockade. Am J Physiol 1977; 01: R80-R87
    PubMedGoogle Scholar
  • 17 Kaplan JE, Blumenstock FA, Saba TM. A radial immunodiffusion method for the measurement of rat fibrinogen and fibrin degradation products. Vox Sang 1979; 36: 65-71
    PubMedGoogle Scholar
  • 18 Bjorkman IR. A new method for enumeration of platelets. Acta Haematol 1959; 22: 377-379
    CrossrefPubMedGoogle Scholar
  • 19 Mainland D, Herrera L, Suttcliffe MI. Tables for use with binomial samples. New York University; New York: 1956
    Google Scholar
  • 20 Myhre-Jensen O. Localization of fibrinolytic activity in the kidney and urinary tract of rats and rabbits. Lab Invest 1971; 25: 403-411
    PubMedGoogle Scholar
  • 21 Guinan ME, Astrup T. High fibrinolytic activity in the endothelium of the arteries of the rat. Thromb Res 1980; 19: 333-338
    CrossrefPubMedGoogle Scholar
  • 22 Mosesson MW, Umfleet RA. The cold-insoluble globulin of human plasma. I. Purification, primary characterization and relationship of fibrinogen and other cold-insoluble fraction components. J Biol Chem 1980; 245: 5728-5736
    PubMedGoogle Scholar
  • 23 Ruoslahti E, Vaheri A. Interaction of soluble fibroblast surface antigen with fibrinogen and fibrin. Identity with cold-insoluble globulin of human plasma. J Exp Med 1975; 141: 497-501
    CrossrefPubMedGoogle Scholar
  • 24 Stathakis NE, Mosesson MW, Chen AB, Galanakis DK. Cryoprecipitate of fibrin-fibrinogen complexes induced by cold-insoluble globulin of plasma. Blood 1978; 51: 1211-1222
    PubMedGoogle Scholar
  • 25 Snedeker PW, Kaplan JE, Saba TM. Effect of intravascular coagulation on the vascular clearance of soluble fibrin monomer. Circ Shock 1979; 06: 196-197
    PubMedGoogle Scholar
  • 26 Mosher DF, Schad PE, Kleinman HK. Cross-linking of fibronectin to collagen by blood coagulation Factor XHIa. J Clin Invest 1979; 64: 781-787
    CrossrefPubMedGoogle Scholar
  • 27 Mosher DF, Williams E. Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation. J Lab Clin Med 1978; 91: 729-735
    PubMedGoogle Scholar
  • 28 Scovill WA, Saba TM, Kaplan JE, Bernard H, Powers SR. Deficits in reticuloendothelial humoral mechanisms after trauma. J Trauma 1976; 16: 898-904
    CrossrefPubMedGoogle Scholar
  • 29 Niehaus GD, Schumacker PT, Saba TM. Reticuloendothelial clearance of bloodborne particulates – Relevance to experimental lung microembolization and vascular injury. Ann Surg 1980; 191: 479-487
    CrossrefPubMedGoogle Scholar
  • 30 Kaplan JE, Saba TM. Humoral deficiency and reticuloendothelial depression after traumatic shock. Am J Physiol 1976; 230: 07-14
    PubMedGoogle Scholar
  • 31 Mosher DF. Changes in plasma cold-insoluble globulin concentration during experimental Rocky Mountain Spotted Fever infection in rhesus monkeys. Thromb Res 1976; 09: 37-45
    CrossrefPubMedGoogle Scholar
  • 32 Kaplan IE, Snedeker PW. Maintenance of fibrin solubility by plasma fibronectin. J Lab Clin Med 1980; 98: 1054-1061
    PubMedGoogle Scholar
  • 33 Snedeker PW, Kaplan JE, Saba TM. Effect of traumatic shock and alterations of reticuloendothelial function on the vascular clearance of soluble fibrin. Physiologist 1978; 21: 113
    PubMedGoogle Scholar
  • 34 lilek F, Horman H. Fibronectin (cold-insoluble globulin) V. I. Mediation of fibrin monomer binding to macrophages. Hoppe-Seyler’s Z Physiol Chem 1978; 359: 1603-1605
    PubMedGoogle Scholar
  • 35 Plow EF, Birdwell C, Ginsberg MH. Identification and quantitation of platelet-associated fibronectin antigen. J Clin Invest 1979; 63: 540-543
    CrossrefPubMedGoogle Scholar
  • 36 Bensusan HB, Koh TL, Kenry KG, Murray BA, Culp LA. Evidence that fibronectin is the collagen receptor on platelet membranes. Proc Natl. Acad Sri USA 1978; 75: 5864-5868
    CrossrefPubMedGoogle Scholar
  • 37 Hynes RO, Ali IU, Destree AT, Mautner V, Perkins ME, Senger DR, Wayner DD, Smith KK. A large glycoprotein lost from the surface of transformed cells. Ann NY Acad Sri 1978; 312: 317-342
    PubMedGoogle Scholar
  • 38 Santoro SA, Cunningham LW. Fibronectin and the multiple interaction model for platelet-collagen adhesion. Proc Natl Acad Sri USA 1979; 76: 2644-2648
    CrossrefPubMedGoogle Scholar
  • 39 Engvall E, Ruoslahti E, Miller ES. Affinity of fibronectin to collagen of different genetic types and to fibronectin. J Exp Med 1978; 147: 1584-1595
    CrossrefPubMedGoogle Scholar
  • 40 Lee L. Reticuloendothelial clearance of circulating fibrin in the pathogenesis of the generalized Schwartzman reaction. J Exp Med 1962; 115: 1065-1071
    CrossrefPubMedGoogle Scholar
  • 41 Gans H. Preservation of vascular patency as a function of reticuloendothelial clearance. Surgery 1966; 60: 1216-1223
    PubMedGoogle Scholar
  • 42 Busch C, Saldeen T. Amount of fibrin in different organs after intravenous, intraportal or intra-aortal injection of thrombin in the rat. Thrombos Diathes Haemorrh 1973; 29: 87-93
    PubMedGoogle Scholar
  • 43 Sherman LA, Lee J, Jacobson A. Quantitation of the reticuloendothelial system clearance of soluble fibrin. Br J Haematol 1977; 37: 231-238
    CrossrefPubMedGoogle Scholar
  • 44 Esnouf MP, Marshall R. The effect of blockade on the reticuloendothelial system and of hypotension on the response of dogs to Ancistrodon rhodostoma venom . Clin Sri 1969; 55: 261-272
    PubMedGoogle Scholar
  • 45 Schumacker PT, Saba TM. Augmentation of pulmonary insufficiency during low-grade intravascular coagulation by prior implant of hepatic RE clearance activity. Physiologist 1979; 20: 85
    PubMedGoogle Scholar
  • 46 Niehaus GD, Schumacker PT, Saba TM. Effect of plasma fibronectin (opsonin) deficiency on pulmonary microvascular permeability in sheep during Pseudomonassepticemia. J Appl Physiol 1980; 49: 693-699
    CrossrefPubMedGoogle Scholar
  • 47 Blumenstock FA, Saba TM, Weber P, Laffin R. Biochemical and immunological characterization of human opsonic a2-SB glycoprotein; Its identity with cold-insoluble globulin. J Biol Chem 1978; 253: 4287-4291
    PubMedGoogle Scholar